Valuation: Artivion, Inc.

Market Cap 1.05B 937M 871M 792M 1.49B 99.42B 1.52B 10.46B 4.09B 51.87B 3.94B 3.86B 166B P/E 2026 *
-61.5x
P/E 2027 * 81.2x
Enterprise Value 1.05B 937M 871M 792M 1.49B 99.42B 1.52B 10.46B 4.09B 51.87B 3.94B 3.86B 166B EV / Sales 2026 *
2.14x
EV / Sales 2027 * 1.93x
Free-Float
89.42%
Yield 2026 *
-
Yield 2027 * -
1 day+1.93%
1 week+4.05%
Current month-3.29%
1 month-13.04%
3 months-9.21%
6 months-41.10%
Current year-51.61%
1 week 20.21
Extreme 20.21
22.49
1 month 20.21
Extreme 20.21
25.48
Current year 19.16
Extreme 19.16
46.84
1 year 19.16
Extreme 19.16
48.25
3 years 12.16
Extreme 12.1582
48.25
5 years 9.64
Extreme 9.64
48.25
10 years 9.64
Extreme 9.64
48.25
Manager TitleAgeSince
Chief Executive Officer 59 01/09/2014
Director of Finance/CFO 53 03/12/2023
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 71 30/11/2003
Director/Board Member 66 30/11/2003
Director/Board Member 61 30/04/2012
Date Insider Type Main position Quantity % Market Cap. Importance
10/09/26 Sell

General Counsel

-11,480 0.0235%
03/09/26 Sell

General Counsel

-1,493 0.0031%
19/08/26 Sell

Chief Executive Officer

-70,000 0.1442%
Change 5-day change 1-year change 3-year change Capi.($)
+1.90%+4.05%-46.86%+62.16% 1.05B
+2.24%+6.38%-19.06%+13.66% 178B
+1.11%+8.72%+0.06%+32.96% 121B
+3.40%+5.19%-21.21%+10.32% 108B
+0.41%+3.99%-44.97%-10.22% 75.7B
+1.50%+6.50%+7.08%+83.16% 64.15B
-1.75%-0.72%+17.66%+59.66% 53.49B
+1.81%+5.45%+3.18%-25.81% 51.45B
+2.14%+5.75%-15.10%+26.33% 41.68B
+2.80%+2.03%+31.66%+9.08% 31.5B
Average +1.59%+3.10%-8.75%+26.13% 72.58B
Weighted average by Cap. +1.69%+4.20%-9.92%+21.21%

Financials

2026 *2027 *
Net sales 490M 438M 407M 370M 696M 46.45B 709M 4.89B 1.91B 24.24B 1.84B 1.8B 77.55B 543M 485M 451M 410M 771M 51.45B 785M 5.41B 2.12B 26.84B 2.04B 2B 85.9B
Net income -16.53M -14.76M -13.72M -12.48M -23.47M -1.57B -23.9M -165M -64.46M -817M -62.04M -60.73M -2.61B 11.4M 10.17M 9.45M 8.6M 16.18M 1.08B 16.47M 114M 44.43M 563M 42.76M 41.86M 1.8B
Net Debt - -
Projected Income Statement - Annual - Artivion, Inc.
Logo Artivion, Inc.
Artivion, Inc. is a medical device company focused on developing solutions that address cardiac and vascular surgeons in treating patients with aortic diseases. The Company operates through two segments, which include Medical Devices and Preservation Services. The Medical Devices segment includes sales of aortic stent grafts, surgical sealants, On-X products, and other products. The Preservation Services segment includes services for the preservation of cardiac and vascular implantable human tissues. It has four product families: aortic stent grafts, On-X mechanical heart valves and related surgical products, surgical sealants, and implantable cardiac and vascular human tissues. Its aortic stent grafts include aortic arch stent grafts, abdominal stent grafts, and synthetic vascular grafts. Its surgical sealants include BioGlue Surgical Adhesive products. It is engaged in the endovascular repair of aortic arch disease and the developer of the NEXUS Aortic Arch System.
Employees
1,800
Date Price Change Volume
15/10/26 US$22.04 +2.37% 113,733
14/10/26 US$21.53 +0.80% 488,611
13/10/26 US$21.36 -1.97% 664,563
12/10/26 US$21.79 +2.49% 436,617
09/10/26 US$21.26 +0.24% 343,497
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
BB
MarketScreener Ratings - Artivion, Inc.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
21.53USD
Average target price
42.15USD
Spread / Average Target
+95.77%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Artivion, Inc.
  1. Stock Market
  2. Stocks
  3. AORT Stock